Standpoint Research Recent News
Why The Recent Selloff In Silicon Motion May Have Been Overdone
Abercrombie & Fitch Shorts Might Be Getting Squeezed
NetEase On A Path To $20 EPS By 2019
Standpoint Defends Opko Health, Thinks Bad News Will Reverse Within 3 Months
Taking Profits In Financials? Proceed With Caution
Sell-Side Sentiment On Twitter Following Buyout Chatter Has Not Been Positive
Standpoint's Moas Downgrades Twitter Despite Takeover Speculation
Standpoint Research Shines A Light On 2 Solar Stocks
Moas, O'Leary Agree: Tesla's Valuation Is 'Ridiculous'
Pro: Dow Is 'Overvalued' And Will Test 15,000 Level; There Are Only 'A Few Dozen' S&P Investible Companies
Why Ronnie Moas Is Running From Sothebys
Ronnie Moas Downgrades Nucor To Hold: Here's Why
Moas On Tesla: 'I Wouldn't Pay $180 For This Thing'
This Analyst Is Selling Tesla: $60 Spike Was Just Shorts Exiting Their Positions
Ronnie Moas Downgrades First Solar, Still Likes Canadian Solar
Moas: Nike's PR Move With Pacquiao Doesn't Make Up For Sweatshops
Ronnie Moas Initiates Gilead At Buy; Models Show It's A Top 10 S&P Stock
Ronnie Moas Upgrades Fedex, Also Likes Ralph Lauren, Emerson Electric, Sothebys And Eaton
5 Stocks Ronnie Moas Just Upgraded -- And A Way To Play The Falling Market
Ronnie Moas Upgrades Lexmark And Buckle: Here's Why
Ronnie Moas: KeyCorp Stock Is 'Looking Good'
Ronnie Moas Downgrades Silicon Motion; Recommends Other Stocks To Roll Proceeds Into
Ronnie Moas Downgrades Kite Pharma, Sees $100 Stock Price Through 2018